Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2-propenamide, N-[3-[2-[[4-[2-(dimethylamino)ethoxy]-2-methoxyphenyl]amino]...], trifluoroacetate | 2753348-63-7 | 99.4% | 628.60 | C30H31F3N6O6 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY19617B10MG

Encompass_Preferred

EGFR-IN-1 TFA is an orally active, irreversible small-molecule inhibitor selective for L858R/T790M mutant forms of the epidermal growth factor receptor (EGFR). It potently inhibits gefitinib-resistant EGFR mutants and demonstrates antiproliferative activity in mutant EGFR cell lines, making it suitable for cellular assays and preclinical research.

  • High mutant selectivity for L858R/T790M.
  • Irreversible mode of inhibition.
  • Potent antiproliferative activity in cell models.
  • Supplied as a trifluoroacetate salt for stability.
  • Intended for in vitro and preclinical research use.

Catalog No. 50-002-97929


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.